» Articles » PMID: 19281072

Role of T-lymphocytes and Pro-inflammatory Mediators in the Pathogenesis of Chronic Obstructive Pulmonary Disease

Overview
Publisher Dove Medical Press
Specialty Pulmonary Medicine
Date 2009 Mar 14
PMID 19281072
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the US and a major worldwide healthcare problem. The pathophysiologic mechanisms that drive development and progression of this disease are complex and only poorly understood. While tobacco smoking is the primary risk factor, other disease processes also appear to play a role. Components of the innate immune system (eg, macrophages and neutrophils) have long been believed to be important in the development of COPD. More recent evidence also suggests involvement of the adaptive immune system in pathogenesis of this disease. Here we will review the literature supporting the participation of T-cells in the development of COPD, and comment on the potential antigenic stimuli that may account for these responses. We will further explore the prospective contributions of T-cell derived mediators that could contribute to the inflammation, alveolar wall destruction, and small airway fibrosis of advanced COPD. A better understanding of these complex immune processes will lead to new insights that could result in improved preventative and/or treatment strategies.

Citing Articles

Relationship between systemic immune response index (SIRI) and COPD: a cross-sectional study based on NHANES 2007-2012.

Jia S, Chen Q, Huang W, Wang P, Zeng Y Sci Rep. 2025; 15(1):7887.

PMID: 40050308 PMC: 11885421. DOI: 10.1038/s41598-025-90947-8.


Identification of benzo(a)pyrene-related toxicological targets and their role in chronic obstructive pulmonary disease pathogenesis: a comprehensive bioinformatics and machine learning approach.

Deng J, Wei L, Chen Y, Li X, Zhang H, Wei X BMC Pharmacol Toxicol. 2025; 26(1):33.

PMID: 39962573 PMC: 11834632. DOI: 10.1186/s40360-025-00842-1.


What every clinician should know about inflammation in COPD.

Wechsler M, Wells J ERJ Open Res. 2024; 10(5).

PMID: 39319045 PMC: 11417604. DOI: 10.1183/23120541.00177-2024.


Inverted U-Shaped relationship Between Systemic Immune-Inflammation Index and Pulmonary Function: A Large Population-Based Study in US Adults.

Yuan Q, Xiao L, Zhang Y, Li L, Xia T, Xu Q Int J Chron Obstruct Pulmon Dis. 2024; 19:1971-1987.

PMID: 39247667 PMC: 11379031. DOI: 10.2147/COPD.S471068.


The association of systemic immune-inflammation index with lung function, risk of COPD and COPD severity: A population-based study.

Song Y, Bai X, Ma J PLoS One. 2024; 19(6):e0303286.

PMID: 38875233 PMC: 11178193. DOI: 10.1371/journal.pone.0303286.


References
1.
Barcelo B, Pons J, Fuster A, Sauleda J, Noguera A, Ferrer J . Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol. 2006; 145(3):474-9. PMC: 1809717. DOI: 10.1111/j.1365-2249.2006.03167.x. View

2.
Hill A, Campbell E, Hill S, Bayley D, Stockley R . Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med. 2000; 109(4):288-95. DOI: 10.1016/s0002-9343(00)00507-6. View

3.
Lu H, Ouyang W, Huang C . Inflammation, a key event in cancer development. Mol Cancer Res. 2006; 4(4):221-33. DOI: 10.1158/1541-7786.MCR-05-0261. View

4.
Ogawa E, Elliott W, Hughes F, Eichholtz T, Hogg J, Hayashi S . Latent adenoviral infection induces production of growth factors relevant to airway remodeling in COPD. Am J Physiol Lung Cell Mol Physiol. 2003; 286(1):L189-97. DOI: 10.1152/ajplung.00315.2002. View

5.
Hogg J, Chu F, Utokaparch S, Woods R, Elliott W, Buzatu L . The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004; 350(26):2645-53. DOI: 10.1056/NEJMoa032158. View